Pfizer Rejects Accusations it Infringed COVID-19 Vaccine Assay Technology

“’The alleged patent infringement—asserted uses by Pfizer and BioNTech of the patented invention to generate data from clinical trials in support of seeking FDA approval—are precisely the type of activity that is protected by the ‘safe harbor’ from patent infringement claims under 35 USC § 271(e)(1).”’ – Pfizer Memorandum on Motion to Dismiss Pfizer and … Read more

Federal Court rejects motion for summary judgment in Canadian patent infringement case following voluntary dismissal of parallel US litigation

In a recently released decision, the Federal Court (FC) considered what happens when a patent infringement plaintiff agrees to resolve a dispute in a foreign jurisdiction, but continues to press parallel litigation against the same defendant in Canada. In this case, the defendant sought summary judgment based on the terms of a voluntary dismissal between … Read more